Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Vemurafenib Patent Expiration

Vemurafenib is Used for treating patients with unresectable or metastatic melanoma with BRAFV600E mutation. It was first introduced by Hoffmann La Roche Inc in its drug Zelboraf on Aug 17, 2011.


Vemurafenib Patents

Given below is the list of patents protecting Vemurafenib, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Zelboraf US7504509 Compounds and methods for development of Ret modulators Oct 22, 2026 Hoffmann La Roche
Zelboraf US7863288 NA Jun 20, 2029 Hoffmann La Roche
Zelboraf US8143271 NA Jun 21, 2026 Hoffmann La Roche
Zelboraf US8470818 NA Aug 02, 2026 Hoffmann La Roche
Zelboraf US8741920 Process for the manufacture of pharmaceutically active compounds Jul 27, 2030 Hoffmann La Roche
Zelboraf US9447089 Compositions and uses thereof Jun 06, 2032 Hoffmann La Roche


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Vemurafenib's patents.

Given below is the list recent legal activities going on the following patents of Vemurafenib.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 20 Mar, 2024 US9447089
Payment of Maintenance Fee, 12th Year, Large Entity 27 Sep, 2023 US8143271
Payment of Maintenance Fee, 12th Year, Large Entity 05 Jul, 2022 US7863288
Payment of Maintenance Fee, 8th Year, Large Entity 11 Nov, 2021 US8741920
Payment of Maintenance Fee, 8th Year, Large Entity 28 Dec, 2020 US8470818
Payment of Maintenance Fee, 12th Year, Large Entity 17 Sep, 2020 US7504509
Payment of Maintenance Fee, 4th Year, Large Entity 20 Mar, 2020 US9447089
Payment of Maintenance Fee, 8th Year, Large Entity 27 Sep, 2019 US8143271
Post Issue Communication - Certificate of Correction 22 Jul, 2019 US9447089
Payment of Maintenance Fee, 8th Year, Large Entity 05 Jul, 2018 US7863288



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳